Prospective de novo drug design with deep interactome learning
Abstract De novo drug design aims to generate molecules from scratch that possess specific chemical and pharmacological properties. We present a computational approach utilizing interactome-based deep learning for ligand- and structure-based generation of drug-like molecules. This method capitalizes...
Saved in:
Main Authors: | Kenneth Atz, Leandro Cotos, Clemens Isert, Maria Håkansson, Dorota Focht, Mattis Hilleke, David F. Nippa, Michael Iff, Jann Ledergerber, Carl C. G. Schiebroek, Valentina Romeo, Jan A. Hiss, Daniel Merk, Petra Schneider, Bernd Kuhn, Uwe Grether, Gisbert Schneider |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-47613-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Author Correction: Prospective de novo drug design with deep interactome learning
by: Kenneth Atz, et al.
Published: (2025-01-01) -
The protein interactome of Escherichia coli carbohydrate metabolism.
by: Shomeek Chowdhury, et al.
Published: (2025-01-01) -
State of the interactomes: an evaluation of molecular networks for generating biological insights
by: Sarah N Wright, et al.
Published: (2024-12-01) -
The study of interactome in Russian patients with Usher syndrome to select priority approaches in pathogenetically oriented treatment
by: M.E. Ivanova, et al.
Published: (2019-11-01) -
Discovering the interactome, functions, and clinical relevance of enhancer RNAs in kidney renal clear cell carcinoma
by: Zhaohui Sun, et al.
Published: (2025-01-01)